News

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the pros and cons of biomarker-based ...
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...
Indian American biomedical researcher has reported novel biomarkers for colorectal, bladder, prostate, stomach and pancreatic ...
Cizzle Bio, Inc., a biotechnology company pioneering innovative biomarker blood tests for early detection of lung and gastric ...
Uterine cancer incidence and mortality rates are projected to increase significantly through 2050, according to a study ...
This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform ...
It is called HUNK (acronym of Hormonally Upregulated Neu-associated Kinase) and it is a new biomarker for gastric cancer: it ...
A new study by researchers at the Icahn School of Medicine at Mount Sinai, Memorial Sloan Kettering Cancer Center, and ...
Research highlights improved lung cancer biomarker testing in North America, though delays, costs, and limited satisfaction persist despite clinician awareness.
Article Indicates that Inhibition of PP2A Enhances Immunotherapy Responsewith LIXTE’s Proprietary Compound LB100 PASADENA, ...
Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to ...